Sutent 50 mg (Sunitinib 50 mg) by Pfizer.
Indications: Gastrointestinal stromal tumour (GIST), metastatic renal cell carcinoma and pancreatic neuroendocrine tumours.
Administration: Oral: 50 mg once daily for 4 weeks, then 2 weeks off (schedule 4/2).
Storage: Store below 25–30 °C in the original package. Keep out of the sight and reach of children.
Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only.
| Manufacturer | Pfizer |
| Active ingredient | Sunitinib 50 mg (as malate) per capsule — multi-targeted tyrosine kinase inhibitor. |
| Strength & pack | 28 hard capsules. |
| Form | Hard capsules |
| Storage | Store below 25–30 °C in the original package. Keep out of the sight and reach of children. |
| Regulatory status | Prescription-only medicine (POM). Supplied against a valid prescription / to licensed healthcare professionals only. |